Long-term follow-up of psilocybin-facilitated smoking cessation
The American Journal of Drug and Alcohol Abuse – July 21, 2016
Source: OpenAlex
Summary
A compelling finding suggests psilocybin, a potent hallucinogen, offers considerable promise for smoking cessation. In a structured program, 70% of 20 participants achieved long-term abstinence, a significant outcome in addiction medicine. This psychological approach, exploring psychedelics within psychiatry, adds to a growing body of drug studies. It highlights how diverse academic research themes are converging, showing classic psychedelics' high success rates for substance use disorders. This novel medicine holds potential for lasting change.
Abstract
These results suggest that in the context of a structured treatment program, psilocybin holds considerable promise in promoting long-term smoking abstinence. The present study adds to recent and historical evidence suggesting high success rates when using classic psychedelics in the treatment of addiction. Further research investigating psilocybin-facilitated treatment of substance use disorders is warranted.